BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9007715)

  • 1. Antibodies to E1 and E2/Protein X components of pyruvate dehydrogenase complex in sera of patients with primary biliary cirrhosis.
    Kuroda M; Morito T; Takagi T; Ohira H; Kokubun M; Kojima T; Ono K; Kochi H; Kasukawa R
    J Hepatol; 1996 Dec; 25(6):867-76. PubMed ID: 9007715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
    Chen QY; Rowley MJ; Mackay IR
    Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
    Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S
    Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display.
    Rowley MJ; Scealy M; Whisstock JC; Jois JA; Wijeyewickrema LC; Mackay IR
    J Immunol; 2000 Mar; 164(6):3413-9. PubMed ID: 10706737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural and disease associated autoantibodies to the autoantigen, dihydrolipoamide acetyltransferase, recognise different epitopes.
    Chen QY; Mackay IR; Fida S; Myers MA; Rowley MJ
    J Autoimmun; 1998 Apr; 11(2):151-61. PubMed ID: 9650094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic.
    Sasaki M; Ansari A; Pumford N; van de Water J; Leung PS; Humphries KM; Szweda LI; Nakanuma Y; Roche TE; Coppel RL; Bach JF; Gershwin ME
    J Autoimmun; 2000 Aug; 15(1):51-60. PubMed ID: 10936028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies of sera from patients with primary biliary cirrhosis recognize the alpha subunit of the decarboxylase component of human branched-chain 2-oxo acid dehydrogenase complex.
    Mori T; Ono K; Hakozaki M; Kasukawa R; Kochi H
    J Hepatol; 2001 Jun; 34(6):799-804. PubMed ID: 11451161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis.
    Kadokawa Y; Omagari K; Hazama H; Ohba K; Masuda J; Kinoshita H; Hayashida K; Isomoto H; Mizuta Y; Murase K; Murata I; Kohno S
    Clin Biochem; 2003 May; 36(3):203-10. PubMed ID: 12726929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
    Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
    Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.
    Berg CP; Stein GM; Klein R; Pascu M; Berg T; Kammer W; Priemer M; Nordheim A; Schulze-Osthoff K; Gregor M; Wesselborg S; Berg PA
    Liver Int; 2006 Sep; 26(7):846-55. PubMed ID: 16911468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
    Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
    J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis.
    Zurgil N; Bakimer R; Kaplan M; Youinou P; Shoenfeld Y
    J Clin Immunol; 1991 Sep; 11(5):239-45. PubMed ID: 1795042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenetic analysis of a panel of monoclonal IgG and IgM anti-PDC-E2/X antibodies derived from patients with primary biliary cirrhosis.
    Thomson RK; Davis Z; Palmer JM; Arthur MJ; Yeaman SJ; Chapman CJ; Spellerberg MB; Stevenson FK
    J Hepatol; 1998 Apr; 28(4):582-94. PubMed ID: 9566826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-branched chain 2-oxo acid dehydrogenase complex (BCOADC)-E2 antibody in primary biliary cirrhosis by ELISA using recombinant fusion protein.
    Miyakawa H; Abe K; Kitazawa E; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Kako M
    Autoimmunity; 1999; 30(1):11-20. PubMed ID: 10433090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression.
    Tsuneyama K; Van de Water J; Leung PS; Cha S; Nakanuma Y; Kaplan M; De Lellis R; Coppel R; Ansari A; Gershwin ME
    Hepatology; 1995 Apr; 21(4):1031-7. PubMed ID: 7535733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis.
    Jones DE; Palmer JM; James OF; Yeaman SJ; Bassendine MF; Diamond AG
    Hepatology; 1995 Apr; 21(4):995-1002. PubMed ID: 7705811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis.
    Klein R; Wiebel M; Engelhart S; Berg PA
    Clin Exp Immunol; 1993 May; 92(2):308-16. PubMed ID: 7683589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex.
    Fregeau DR; Davis PA; Danner DJ; Ansari A; Coppel RL; Dickson ER; Gershwin ME
    J Immunol; 1989 Jun; 142(11):3815-20. PubMed ID: 2715637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.